×

Cubist Pharma CEO Talks New Lineup

6:45 PM ET Mon, 29 April 2013

Cubist Pharmaceuticals is up nearly 9 percent over the last year and has rallied almost 12 percent year-to-date. Michael Bonney, Cubist Pharmaceuticals CEO, weighs in.